Biology:Adegramotide

From HandWiki
Short description: Experimental cancer drug
Adegramotide
Adegramotide.svg
Legal status
Legal status
  • experimental
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
Chemical and physical data
FormulaC87H123N19O24
Molar mass1819.050 g·mol−1
3D model (JSmol)

Adegramotide (DSP-7888) is an experimental drug intended for treatment of glioblastoma multiforme.[1] It is a peptide vaccine and, as of 2017, in phase II clinical trials.[2][3]

References